The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Vaccines for Infectious Diseases Market Research Report 2025
Synopsis
The global mRNA Vaccines for Infectious Diseases market was valued at US$ 31050 million in 2023 and is anticipated to reach US$ 36820 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines for Infectious Diseases.
Report Scope
The mRNA Vaccines for Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccines for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines for Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccines for Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global mRNA Vaccines for Infectious Diseases market was valued at US$ 31050 million in 2023 and is anticipated to reach US$ 36820 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines for Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines for Infectious Diseases.
Report Scope
The mRNA Vaccines for Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccines for Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines for Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccines for Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Vaccines for Infectious Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccines for Infectious Diseases Market Perspective (2019-2030)
2.2 mRNA Vaccines for Infectious Diseases Growth Trends by Region
2.2.1 Global mRNA Vaccines for Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Vaccines for Infectious Diseases Historic Market Size by Region (2019-2024)
2.2.3 mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2025-2030)
2.3 mRNA Vaccines for Infectious Diseases Market Dynamics
2.3.1 mRNA Vaccines for Infectious Diseases Industry Trends
2.3.2 mRNA Vaccines for Infectious Diseases Market Drivers
2.3.3 mRNA Vaccines for Infectious Diseases Market Challenges
2.3.4 mRNA Vaccines for Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue
3.1.1 Global Top mRNA Vaccines for Infectious Diseases Players by Revenue (2019-2024)
3.1.2 Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Vaccines for Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Vaccines for Infectious Diseases Revenue
3.4 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio
3.4.1 Global mRNA Vaccines for Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccines for Infectious Diseases Revenue in 2023
3.5 mRNA Vaccines for Infectious Diseases Key Players Head office and Area Served
3.6 Key Players mRNA Vaccines for Infectious Diseases Product Solution and Service
3.7 Date of Enter into mRNA Vaccines for Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Vaccines for Infectious Diseases Breakdown Data by Type
4.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Type (2019-2024)
4.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2025-2030)
5 mRNA Vaccines for Infectious Diseases Breakdown Data by Application
5.1 Global mRNA Vaccines for Infectious Diseases Historic Market Size by Application (2019-2024)
5.2 Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Vaccines for Infectious Diseases Market Size (2019-2030)
6.2 North America mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024)
6.4 North America mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Vaccines for Infectious Diseases Market Size (2019-2030)
7.2 Europe mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024)
7.4 Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size (2019-2030)
8.2 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Vaccines for Infectious Diseases Market Size (2019-2030)
9.2 Latin America mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024)
9.4 Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size (2019-2030)
10.2 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Moderna Therapeutics
11.1.1 Moderna Therapeutics Company Detail
11.1.2 Moderna Therapeutics Business Overview
11.1.3 Moderna Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.1.4 Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.1.5 Moderna Therapeutics Recent Development
11.2 CureVac
11.2.1 CureVac Company Detail
11.2.2 CureVac Business Overview
11.2.3 CureVac mRNA Vaccines for Infectious Diseases Introduction
11.2.4 CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.2.5 CureVac Recent Development
11.3 Translate Bio
11.3.1 Translate Bio Company Detail
11.3.2 Translate Bio Business Overview
11.3.3 Translate Bio mRNA Vaccines for Infectious Diseases Introduction
11.3.4 Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.3.5 Translate Bio Recent Development
11.4 BioNTech
11.4.1 BioNTech Company Detail
11.4.2 BioNTech Business Overview
11.4.3 BioNTech mRNA Vaccines for Infectious Diseases Introduction
11.4.4 BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.4.5 BioNTech Recent Development
11.5 Sangamo Therapeutics
11.5.1 Sangamo Therapeutics Company Detail
11.5.2 Sangamo Therapeutics Business Overview
11.5.3 Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.5.4 Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.5.5 Sangamo Therapeutics Recent Development
11.6 Argos Therapeutics
11.6.1 Argos Therapeutics Company Detail
11.6.2 Argos Therapeutics Business Overview
11.6.3 Argos Therapeutics mRNA Vaccines for Infectious Diseases Introduction
11.6.4 Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.6.5 Argos Therapeutics Recent Development
11.7 In-Cell-Art
11.7.1 In-Cell-Art Company Detail
11.7.2 In-Cell-Art Business Overview
11.7.3 In-Cell-Art mRNA Vaccines for Infectious Diseases Introduction
11.7.4 In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.7.5 In-Cell-Art Recent Development
11.8 eTheRNA
11.8.1 eTheRNA Company Detail
11.8.2 eTheRNA Business Overview
11.8.3 eTheRNA mRNA Vaccines for Infectious Diseases Introduction
11.8.4 eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.8.5 eTheRNA Recent Development
11.9 Ethris
11.9.1 Ethris Company Detail
11.9.2 Ethris Business Overview
11.9.3 Ethris mRNA Vaccines for Infectious Diseases Introduction
11.9.4 Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.9.5 Ethris Recent Development
11.10 Tiba Biotechnology
11.10.1 Tiba Biotechnology Company Detail
11.10.2 Tiba Biotechnology Business Overview
11.10.3 Tiba Biotechnology mRNA Vaccines for Infectious Diseases Introduction
11.10.4 Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024)
11.10.5 Tiba Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Infectious Disease Vaccines
Table 3. Key Players of Cancer Vaccines
Table 4. Global mRNA Vaccines for Infectious Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global mRNA Vaccines for Infectious Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global mRNA Vaccines for Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2019-2024)
Table 8. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global mRNA Vaccines for Infectious Diseases Market Share by Region (2025-2030)
Table 10. mRNA Vaccines for Infectious Diseases Market Trends
Table 11. mRNA Vaccines for Infectious Diseases Market Drivers
Table 12. mRNA Vaccines for Infectious Diseases Market Challenges
Table 13. mRNA Vaccines for Infectious Diseases Market Restraints
Table 14. Global mRNA Vaccines for Infectious Diseases Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global mRNA Vaccines for Infectious Diseases Market Share by Players (2019-2024)
Table 16. Global Top mRNA Vaccines for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2023)
Table 17. Ranking of Global Top mRNA Vaccines for Infectious Diseases Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by mRNA Vaccines for Infectious Diseases Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players mRNA Vaccines for Infectious Diseases Product Solution and Service
Table 21. Date of Enter into mRNA Vaccines for Infectious Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Vaccines for Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2019-2024)
Table 25. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Type (2025-2030)
Table 27. Global mRNA Vaccines for Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Application (2019-2024)
Table 29. Global mRNA Vaccines for Infectious Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global mRNA Vaccines for Infectious Diseases Revenue Market Share by Application (2025-2030)
Table 31. North America mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 46. Moderna Therapeutics Company Detail
Table 47. Moderna Therapeutics Business Overview
Table 48. Moderna Therapeutics mRNA Vaccines for Infectious Diseases Product
Table 49. Moderna Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 50. Moderna Therapeutics Recent Development
Table 51. CureVac Company Detail
Table 52. CureVac Business Overview
Table 53. CureVac mRNA Vaccines for Infectious Diseases Product
Table 54. CureVac Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 55. CureVac Recent Development
Table 56. Translate Bio Company Detail
Table 57. Translate Bio Business Overview
Table 58. Translate Bio mRNA Vaccines for Infectious Diseases Product
Table 59. Translate Bio Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 60. Translate Bio Recent Development
Table 61. BioNTech Company Detail
Table 62. BioNTech Business Overview
Table 63. BioNTech mRNA Vaccines for Infectious Diseases Product
Table 64. BioNTech Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 65. BioNTech Recent Development
Table 66. Sangamo Therapeutics Company Detail
Table 67. Sangamo Therapeutics Business Overview
Table 68. Sangamo Therapeutics mRNA Vaccines for Infectious Diseases Product
Table 69. Sangamo Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 70. Sangamo Therapeutics Recent Development
Table 71. Argos Therapeutics Company Detail
Table 72. Argos Therapeutics Business Overview
Table 73. Argos Therapeutics mRNA Vaccines for Infectious Diseases Product
Table 74. Argos Therapeutics Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 75. Argos Therapeutics Recent Development
Table 76. In-Cell-Art Company Detail
Table 77. In-Cell-Art Business Overview
Table 78. In-Cell-Art mRNA Vaccines for Infectious Diseases Product
Table 79. In-Cell-Art Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 80. In-Cell-Art Recent Development
Table 81. eTheRNA Company Detail
Table 82. eTheRNA Business Overview
Table 83. eTheRNA mRNA Vaccines for Infectious Diseases Product
Table 84. eTheRNA Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 85. eTheRNA Recent Development
Table 86. Ethris Company Detail
Table 87. Ethris Business Overview
Table 88. Ethris mRNA Vaccines for Infectious Diseases Product
Table 89. Ethris Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 90. Ethris Recent Development
Table 91. Tiba Biotechnology Company Detail
Table 92. Tiba Biotechnology Business Overview
Table 93. Tiba Biotechnology mRNA Vaccines for Infectious Diseases Product
Table 94. Tiba Biotechnology Revenue in mRNA Vaccines for Infectious Diseases Business (2019-2024) & (US$ Million)
Table 95. Tiba Biotechnology Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccines for Infectious Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global mRNA Vaccines for Infectious Diseases Market Share by Type: 2023 VS 2030
Figure 3. Infectious Disease Vaccines Features
Figure 4. Cancer Vaccines Features
Figure 5. Global mRNA Vaccines for Infectious Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global mRNA Vaccines for Infectious Diseases Market Share by Application: 2023 VS 2030
Figure 7. Infectious Disease Case Studies
Figure 8. Cancer Case Studies
Figure 9. mRNA Vaccines for Infectious Diseases Report Years Considered
Figure 10. Global mRNA Vaccines for Infectious Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global mRNA Vaccines for Infectious Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global mRNA Vaccines for Infectious Diseases Market Share by Region: 2023 VS 2030
Figure 13. Global mRNA Vaccines for Infectious Diseases Market Share by Players in 2023
Figure 14. Global Top mRNA Vaccines for Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines for Infectious Diseases as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by mRNA Vaccines for Infectious Diseases Revenue in 2023
Figure 16. North America mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America mRNA Vaccines for Infectious Diseases Market Share by Country (2019-2030)
Figure 18. United States mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe mRNA Vaccines for Infectious Diseases Market Share by Country (2019-2030)
Figure 22. Germany mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific mRNA Vaccines for Infectious Diseases Market Share by Region (2019-2030)
Figure 30. China mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America mRNA Vaccines for Infectious Diseases Market Share by Country (2019-2030)
Figure 38. Mexico mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa mRNA Vaccines for Infectious Diseases Market Share by Country (2019-2030)
Figure 42. Turkey mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia mRNA Vaccines for Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 45. CureVac Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 46. Translate Bio Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 47. BioNTech Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 48. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 49. Argos Therapeutics Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 50. In-Cell-Art Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 51. eTheRNA Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 52. Ethris Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 53. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccines for Infectious Diseases Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
